N | Mean | Value | p | ||||
---|---|---|---|---|---|---|---|
Age (year) | Total | 191 | 54,32±17,95 | min= 20, | max: 95 | ||
Survivor | 156 | 50,10±15,76 | min= 20, | max: 93 | t= -7,88 | <0,001 | |
Non-survivor | 35 | 73,11±14,94 | min= 23, | max: 95 | |||
N | % | Mortality | |||||
Sex | Female | 97 | 50.8% | n=18 | 18.6% | ||
Male | 94 | 49.2% | n=17 | 18.1% | χ2=0,007 | 0,933 | |
Center | First center | 126 | 66.0% | n=32 | 25.4% | ||
Second center | 65 | 34.0% | n=3 | 4.6% | χ2=12,37 | <0,001 | |
Symptoms | Yes | 183 | 95.8% | n=35 | 19.1% | 0,355* | |
No | 8 | 4.2% | n=0 | 0.0% | |||
Fever | Yes | 135 | 70.7% | survivor | n=111; 71.2% | ||
No | 56 | 29.3% | non-survivor | n=24; 68.6% | χ2=0,092 | 0,762 | |
Cough | Yes | 117 | 61.3% | survivor | n=95; 60.9% | ||
No | 74 | 38.7% | non-survivor | n=22; 62.9% | χ2=0,046 | 0,830 | |
Fatigue | Yes | 108 | 56.5% | survivor | n=87; 55.8% | ||
No | 83 | 43.5% | non-survivor | n=21; 60.0% | χ2=0,208 | 0,648 | |
Dyspnea | Yes | 64 | 33.5% | survivor | n= 40; 25.6% | χ2=23,65 | <0,001 |
No | 127 | 66.5% | non-survivor | n= 24; 68.6% | |||
Myalgia | Yes | 53 | 27.7% | survivor | n= 48; 30.8% | ||
No | 138 | 72.3% | non-survivor | n=5; 14.3% | χ2=3,87 | 0,049 | |
Diarrhea | Yes | 31 | 16.2% | survivor | n=25; 16.0% | ||
No | 160 | 83.8% | non-survivor | n=6; 17.1% | χ2=0,026 | 0,871 | |
Loss of taste | Yes | 16 | 8.4% | survivor | n=13; 8.3% | χ2=0,02 | 0,963 |
and smell | No | 175 | 91.6% | non-survivor | n=3; 8.6% | ||
Thoracic CT | Positive | 168 | 88.0% | Mortality | 20.3% | 0,009* | |
scan | Negative | 23 | 12.0% | Mortality | 0.0% | ||
Ground-opacity glass | 164 | 85.9% | Mortality n=33 | 20.1% | χ2=2,50 | 0,114 | |
Consolidation | 68 | 35.6% | Mortality n=20 | 29.4% | χ2=8,67 | 0,003 |
Total median/ min-max | Survivor (median) | Non-survivor (median) | N | % | Mortality rate (%) | U | p | ||
---|---|---|---|---|---|---|---|---|---|
WBC | 6000 | 6000 | 5700 | <4500 | 41 | 21.5 | 2580,0 | 0,612 | |
(x106/L) | (1500-19000) | 4500-10500 | 135 | 70.7 | |||||
>10500 | 15 | 7.8 | |||||||
Lymphocyte | 1200 | 1355 | 700 | <1000 | 77 | 40,3 | 988,0 | ||
(x106/L) | (200-3600) | >1001 | 114 | 59,7 | |||||
Neutrophil | 3970 | 3835,0 | 4750,0 | 1942,5 | |||||
(x106/L) | (290-16260) | ||||||||
Eosinophil | 10,0 | 20,0 | 10,0 | 2042,0 | |||||
(x106/L) | (0,00-640,0) | ||||||||
Total (median) | Survivor (median) | Non-survivor (median) | Cut-off | Total N | % | ||||
Hemoglobin | 13,3 | 13,55 | 10,90 | 871,0 | |||||
(g/dL) | (5,7-17,4) | ||||||||
PLT | 178,0 | 178,0 | 178,0 | 2639,5 | 0,759 | ||||
(x109/L) | (14-653) | ||||||||
RDW | 13,5 | 13,46 | 15,14 | 1458,0 | |||||
(%) | (2,6-24,0) | (±1,56) | (±2,43) | ||||||
SII-Index | 585,96 | 495,52 | 1477,78 | <618,8 | 103 | 53.9 | 6.8% | 1357,0 | |
(27,84-15062,5) | >618,9 | 88 | 46.1 | 31.8% | |||||
NLR | 3,31 | 2,73 | 9,27 | <4,21 | 123 | 64.4 | 6.5% | 1038,5 | |
(0,29-43,8) | >4,21 | 68 | 35.6 | 39.7% | |||||
PLR | 151,46 | 139,94 | 287,5 | <189,5 | 132 | 69.1 | 6.1% | 1144,0 | |
(16,09-1425,0) | >189,6 | 59 | 30.9 | 45.8% |
N | % | Value | p | |||
---|---|---|---|---|---|---|
AKI | 31 | 16.2 % | survivor | n=16; 10.3% | χ2=22,35 | <0,001 |
non-survivor | n=15; 42.9% | |||||
Renal Tx | 6 | 3.1 % | survivor | n=5; 3.2% | 1,000 | |
non-survivor | n=1; 2.9% | (Fisher’s) | ||||
CKD | 28 | 14.7 % | survivor | n=10; 6.4% | χ2=46,31 | <0,001 |
non-survivor | n=18; 51.4% | |||||
Hypertension | 72 | 37.7 % | survivor | n= 42; 26.9% | χ2=42,07 | <0,001 |
non-survivor | n= 30; 85.7% | |||||
Diabetes | 44 | 23.0 % | survivor | n= 26; 16.7% | χ2=19,48 | <0,001 |
non-survivor | n= 18; 51.4% | |||||
Heart failure | 15 | 7.9 % | survivor | n= 7; 4,5% | χ2=13,33 | <0,001 |
non-survivor | n= 8; 22,9% | |||||
median | Min.-max. | median | U | p | ||
Creatinine | 0,88 | 0,44-15,36 | survivor | 0,825 | 1230,5 | <0,001 |
(mg/dL) | non-survivor | 1,52 | ||||
eGFR (CKD-Epi) | 88,13 | 3,02-133,44 | survivor | 94,19 | 808,5 | <0,001 |
(ml/dk) | non-survivor | 41,74 | ||||
LDH | 343,0 | 155-25000 | survivor | 284,0 | 779,5 | <0,001 |
(U/L) | non-survivor | 408,0 | ||||
CRP | 9,81 | 0,36-35,25 | survivor | 5,80 | 856,5 | <0,001 |
(mg/dL) | non-survivor | 12,54 | ||||
Ferritin | 538 | 9-40000 | survivor | 192,0 | 345,5 | <0,001 |
(ng/mL) | non-survivor | 861,0 | ||||
D-Dimer | 1130 | 0,52-6160 | survivor | 880,0 | 1095,0 | 0,252 |
(ng/mL) | non-survivor | 1575,0 | ||||
Troponin-I | 22,9 | 10-932 | survivor | 10,0 | 466,0 | <0,001 |
(ng/mL) | non-survivor | 44,8 | ||||
Procalcitonin | 0,13 | 0,05-28,34 | survivor | 0,05 | 299,5 | <0,001 |
(ng/mL) | non-survivor | 0,62 |